{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:56:48Z","timestamp":1780765008095,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Joint Funds for the innovation of science and Technology, Fujian province","award":["2021Y9072"],"award-info":[{"award-number":["2021Y9072"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Heteroresistance can lead to treatment failure and has brought a rigorous challenge to clinical laboratories for detecting them. The aim of this study was to investigate the potential for tigecycline-susceptible <jats:italic>Klebsiella pneumoniae (K. pneumoniae)<\/jats:italic> clinical isolates to develop heteroresistance under antibiotic pressure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>In this study, inducing experiment in vitro was used to acquire tigecycline heteroresistance phenotype. Population analysis profiling was used to confirm heteroresistance. Potential tigecycline heteroresistance mechanism through whole-genome sequencing and quantitative reverse-transcription PCR (qRT-PCR) were explored. Time-kill assay was used to explore the effect of tigecycline monotherapy or combination with other antibiotics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result<\/jats:title>\n            <jats:p>Two clinically isolated <jats:italic>K. pneumonia<\/jats:italic> strains were found to change from tigecycline susceptible to resistance during treatment of tigecycline in vivo. Experimental-evolved tigecycline heteroresistant colonies were successfully obtained by exposing to concentration of tigecycline at usual therapy of tigecycline (serum concentration of 0.1\u00a0mg\/L). Heteroresistant phenotypes were stable, and the minimal inhibitory concentration sustained at resistant after 7 days serially passed in tigecycline-free medium. Frequency of heteroresistant subpopulation ranged from 7.0\u2009\u00d7\u200910<jats:sup>\u22127<\/jats:sup> to 1.41\u2009\u00d7\u200910<jats:sup>\u22126<\/jats:sup>. Genome sequencing and analysis showed mutations of <jats:italic>ramR<\/jats:italic>,<jats:italic> acrR<\/jats:italic> and <jats:italic>rpsJ<\/jats:italic> could be responsible for the stage from tigecycline susceptible to heteroresistance and further to resistance in <jats:italic>K. pneumoniae<\/jats:italic>. Quantitative reverse-transcription PCR analysis revealed that the increased expression of tigecycline resistance genes detected in tigecycline resistant subpopulations might be associated with tigecycline heteroresistance. Time-kill assay showed the impaired efficacy of serum concentrations of 0.1\u00a0mg\/L tigecycline (50\u00a0mg\/q12h intravenously [i.v.]) monotherapy on tigecycline susceptible <jats:italic>K. pneumoniae<\/jats:italic>. 1\u00a0mg\/L tigecycline could be effective in preventing susceptible strain but failed on heteroresistance. Combination with other antibiotics which are susceptible to target strains such as tigecycline-polymyxin B and tigecycline-amikacin can effectively inhibit the growth of resistant subpopulations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The findings reveal the phenomenon where tigecycline may induce resistance in initially susceptible strains during clinical treatment, associated with several mutations of <jats:italic>ramR<\/jats:italic>,<jats:italic> acrR and rpsJ<\/jats:italic>, resulting in treatment failure. The heteroresistant strains induced by low concentrations of tigecycline in vitro provide a perspective for exploring the molecular mechanisms of tigecycline resistance in <jats:italic>K. pneumoniae<\/jats:italic>. Combination with other antibiotics like polymyxin B and amikacin would show synergistic effects in evading regrowth of resistant subpopulations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12941-025-00815-6","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:21:29Z","timestamp":1759227689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Heteroresistance is associated with mutations during low concentration of tigecycline therapy in multiple-resistant Klebsiella pneumoniae"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0615-0048","authenticated-orcid":false,"given":"Qiaoyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"4","key":"815_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/jac\/dki291","volume":"56","author":"DM Livermore","year":"2005","unstructured":"Livermore DM. Tigecycline: what is it, and where should it be used? J Antimicrob Chemother. 2005;56(4):611\u20134.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"815_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3349\/ymj.2016.57.3.641","volume":"57","author":"C Ahn","year":"2016","unstructured":"Ahn C, Yoon SS, Yong TS, Jeong SH, Lee K. The resistance mechanism and clonal distribution of Tigecycline-nonsusceptible Klebsiella pneumoniae isolates in Korea. Yonsei Med J. 2016;57(3):641\u20136.","journal-title":"Yonsei Med J"},{"issue":"3","key":"815_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1128\/AAC.06053-11","volume":"56","author":"YH Chen","year":"2012","unstructured":"Chen YH, Lu PL, Huang CH, Liao CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, et al. Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline in vitro surveillance in Taiwan study, 2006 to 2010. Antimicrob Agents Chemother. 2012;56(3):1452\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"815_CR4","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1128\/AAC.01499-05","volume":"50","author":"MW Olson","year":"2006","unstructured":"Olson MW, Ruzin A, Feyfant E, Rush TS, O\u2019Connell J, Bradford PA. Functional, biophysical, and structural bases for antibacterial activity of Tigecycline. Antimicrob Agents Chemother. 2006;50(6):2156\u201366.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"815_CR5","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1128\/AAC.49.4.1636-1638.2005","volume":"49","author":"AC Fluit","year":"2005","unstructured":"Fluit AC, Florijn A, Verhoef J, Milatovic D. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline. Antimicrob Agents Chemother. 2005;49(4):1636\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"815_CR6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/jac\/dks535","volume":"68","author":"S Roy","year":"2013","unstructured":"Roy S, Datta S, Viswanathan R, Singh AK, Basu S. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility. J Antimicrob Chemother. 2013;68(5):1036\u201342.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"815_CR7","doi-asserted-by":"publisher","first-page":"e0119064","DOI":"10.1371\/journal.pone.0119064","volume":"10","author":"F He","year":"2015","unstructured":"He F, Fu Y, Chen Q, Ruan Z, Hua X, Zhou H, Yu Y. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae. PLoS One. 2015;10(3):e0119064.","journal-title":"PLoS One"},{"issue":"1","key":"815_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/jac\/dkq421","volume":"66","author":"T Horiyama","year":"2011","unstructured":"Horiyama T, Nikaido E, Yamaguchi A, Nishino K. Roles of Salmonella multidrug efflux pumps in Tigecycline resistance. J Antimicrob Chemother. 2011;66(1):105\u201310.","journal-title":"J Antimicrob Chemother"},{"key":"815_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13756-019-0489-3","volume":"8","author":"J Li","year":"2019","unstructured":"Li J, Zhang H, Ning J, Sajid A, Cheng G, Yuan Z, Hao H. The nature and epidemiology of oqxab, a multidrug efflux pump. Antimicrob Resist Infect Control. 2019;8:44.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"815_CR10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/jac\/dks530","volume":"68","author":"M Veleba","year":"2013","unstructured":"Veleba M, De Majumdar S, Hornsey M, Woodford N, Schneiders T. Genetic characterization of Tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Antimicrob Chemother. 2013;68(5):1011\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"815_CR11","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1128\/AAC.06224-11","volume":"56","author":"M Veleba","year":"2012","unstructured":"Veleba M, Schneiders T. Tigecycline resistance can occur independently of the RamA gene in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2012;56(8):4466\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"815_CR12","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1128\/AAC.00156-11","volume":"55","author":"S Bialek-Davenet","year":"2011","unstructured":"Bialek-Davenet S, Marcon E, Leflon-Guibout V, Lavigne JP, Bert F, Moreau R, Nicolas-Chanoine MH. In vitro selection of RamR and SoxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2011;55(6):2795\u2013802.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"815_CR13","doi-asserted-by":"publisher","first-page":"e0165019","DOI":"10.1371\/journal.pone.0165019","volume":"11","author":"L Fang","year":"2016","unstructured":"Fang L, Chen Q, Shi K, Li X, Shi Q, He F, Zhou J, Yu Y, Hua X. Step-wise increase in Tigecycline resistance in Klebsiella pneumoniae associated with mutations in ramr, Lon and RpsJ. PLoS One. 2016;11(10):e0165019.","journal-title":"PLoS One"},{"key":"815_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00391-17","author":"SK Chiu","year":"2017","unstructured":"Chiu SK, Huang LY, Chen H, Tsai YK, Liou CH, Lin JC, Siu LK, Chang FY, Yeh KM. Roles of RamR and tet(A) mutations in conferring tigecycline resistance in Carbapenem-Resistant Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother. 2017. https:\/\/doi.org\/10.1128\/AAC.00391-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"815_CR15","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.00085-10","volume":"54","author":"M Hentschke","year":"2010","unstructured":"Hentschke M, Wolters M, Sobottka I, Rohde H, Aepfelbacher M. RamR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline. Antimicrob Agents Chemother. 2010;54(6):2720\u20133.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"815_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ijantimicag.2014.12.022","volume":"45","author":"X Wang","year":"2015","unstructured":"Wang X, Chen H, Zhang Y, Wang Q, Zhao C, Li H, He W, Zhang F, Wang Z, Li S, et al. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: role of the global regulator RamA and its local repressor RamR. Int J Antimicrob Agents. 2015;45(6):635\u201340.","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"815_CR17","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1128\/AAC.00547-15","volume":"59","author":"K Beabout","year":"2015","unstructured":"Beabout K, Hammerstrom TG, Perez AM, Magalhaes BF, Prater AG, Clements TP, Arias CA, Saxer G, Shamoo Y. The ribosomal S10 protein is a general target for decreased tigecycline susceptibility. Antimicrob Agents Chemother. 2015;59(9):5561\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"815_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jgar.2022.07.023","volume":"31","author":"M Haeili","year":"2022","unstructured":"Haeili M, Shoghi Y, Moghimi M, Ghodousi A, Omrani M, Cirillo DM. Genomic features of in vitro selected mutants of Escherichia coli with decreased susceptibility to Tigecycline. J Glob Antimicrob Resist. 2022;31:32\u20137.","journal-title":"J Glob Antimicrob Resist"},{"issue":"7","key":"815_CR19","doi-asserted-by":"publisher","first-page":"e3001346","DOI":"10.1371\/journal.pbio.3001346","volume":"19","author":"VI Band","year":"2021","unstructured":"Band VI, Weiss DS. Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance. PLoS Biol. 2021;19(7):e3001346.","journal-title":"PLoS Biol"},{"key":"815_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02957","volume":"10","author":"YF Zhou","year":"2019","unstructured":"Zhou YF, Liu P, Zhang CJ, Liao XP, Sun J, Liu YH. Colistin combined with tigecycline: a promising alternative strategy to combat Escherichia coli harboring Bla (NDM-) (5) and mcr-1. Front Microbiol. 2019;10: 2957.","journal-title":"Front Microbiol"},{"issue":"11","key":"815_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003126","volume":"95","author":"W Ni","year":"2016","unstructured":"Ni W, Han Y, Liu J, Wei C, Zhao J, Cui J, Wang R, Liu Y. Tigecycline treatment for Carbapenem-Resistant Enterobacteriaceae infections: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(11): e3126.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"815_CR22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/jac\/dkr007","volume":"66","author":"G Meletis","year":"2011","unstructured":"Meletis G, Tzampaz E, Sianou E, Tzavaras I, Sofianou D. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2011;66(4):946\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"815_CR23","doi-asserted-by":"publisher","first-page":"671153","DOI":"10.3389\/fmicb.2021.671153","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Lin L, Pan Y, Chen J. Characterization of tigecycline-heteroresistant Klebsiella pneumoniae clinical isolates from a Chinese tertiary care teaching hospital. Front Microbiol. 2021;12:671153.","journal-title":"Front Microbiol"},{"key":"815_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13104-016-1900-2","volume":"9","author":"M Schubert","year":"2016","unstructured":"Schubert M, Lindgreen S, Orlando L. Adapterremoval v2: rapid adapter trimming, identification, and read merging. BMC Res Notes. 2016;9:88.","journal-title":"BMC Res Notes"},{"issue":"5","key":"815_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/cmb.2012.0021","volume":"19","author":"A Bankevich","year":"2012","unstructured":"Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455\u201377.","journal-title":"J Comput Biol"},{"issue":"4","key":"815_CR26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/bioinformatics\/btu661","volume":"31","author":"D Coil","year":"2015","unstructured":"Coil D, Jospin G, Darling AE. A5-miseq: an updated pipeline to assemble microbial genomes from illumina miseq data. Bioinformatics. 2015;31(4):587\u20139.","journal-title":"Bioinformatics"},{"issue":"6","key":"815_CR27","doi-asserted-by":"publisher","first-page":"e1005595","DOI":"10.1371\/journal.pcbi.1005595","volume":"13","author":"RR Wick","year":"2017","unstructured":"Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13(6):e1005595.","journal-title":"PLoS Comput Biol"},{"issue":"11","key":"815_CR28","doi-asserted-by":"publisher","first-page":"e112963","DOI":"10.1371\/journal.pone.0112963","volume":"9","author":"BJ Walker","year":"2014","unstructured":"Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A, Sakthikumar S, Cuomo CA, Zeng Q, Wortman J, Young SK, et al. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS One. 2014;9(11):e112963.","journal-title":"PLoS One"},{"issue":"16","key":"815_CR29","doi-asserted-by":"publisher","first-page":"9077","DOI":"10.1093\/nar\/gkab688","volume":"49","author":"PP Chan","year":"2021","unstructured":"Chan PP, Lin BY, Mak AJ, Lowe TM. tRNAscan-SE 2.0: improved detection and functional classification of transfer RNA genes. Nucleic Acids Res. 2021;49(16):9077\u201396.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"815_CR30","doi-asserted-by":"publisher","first-page":"D130","DOI":"10.1093\/nar\/gku1063","volume":"43","author":"EP Nawrocki","year":"2015","unstructured":"Nawrocki EP, Burge SW, Bateman A, Daub J, Eberhardt RY, Eddy SR, Floden EW, Gardner PP, Jones TA, Tate J, et al. Rfam 12.0: updates to the RNA families database. Nucleic Acids Res. 2015;43(Database issue):D130\u2013137.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"815_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks406","volume":"40","author":"S Akhter","year":"2012","unstructured":"Akhter S, Aziz RK, Edwards RA. PhiSpy: a novel algorithm for finding prophages in bacterial genomes that combines similarity- and composition-based strategies. Nucleic Acids Res. 2012;40(16): e126.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"815_CR32","doi-asserted-by":"publisher","first-page":"W30","DOI":"10.1093\/nar\/gkx343","volume":"45","author":"C Bertelli","year":"2017","unstructured":"Bertelli C, Laird MR, Williams KP, Simon Fraser University Research, Computing G, Lau BY, Hoad G, Winsor GL, Brinkman FSL. IslandViewer 4: expanded prediction of genomic Islands for larger-scale datasets. Nucleic Acids Res. 2017;45(W1):W30\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"815_CR33","doi-asserted-by":"publisher","first-page":"622","DOI":"10.21037\/apm.2019.09.11","volume":"8","author":"J Zhang","year":"2019","unstructured":"Zhang J, Yu L, Fu Y, Zhao Y, Wang Y, Zhao J, Guo Y, Li C, Zhang X. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro. Ann Palliat Med. 2019;8(5):622\u201331.","journal-title":"Ann Palliat Med"},{"issue":"3","key":"815_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.diagmicrobio.2005.05.006","volume":"52","author":"AK Meagher","year":"2005","unstructured":"Meagher AK, Ambrose PG, Grasela TH, Ellis-Grosse EJ. Pharmacokinetic\/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent. Diagn Microbiol Infect Dis. 2005;52(3):165\u201371.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"815_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.diagmicrobio.2018.06.013","volume":"92","author":"B Kulengowski","year":"2018","unstructured":"Kulengowski B, Rutter WC, Campion JJ, Lee GC, Feola DJ, Burgess DS. Effect of increasing meropenem MIC on the killing activity of meropenem in combination with amikacin or polymyxin B against MBL- and KPC-producing Enterobacter cloacae. Diagn Microbiol Infect Dis. 2018;92(3):262\u20136.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"815_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijantimicag.2017.03.011","volume":"50","author":"W Yu","year":"2017","unstructured":"Yu W, Shen P, Bao Z, Zhou K, Zheng B, Ji J, Guo L, Huang C, Xiao Y. In vitro antibacterial activity of fosfomycin combined with other antimicrobials against KPC-producing Klebsiella pneumoniae. Int J Antimicrob Agents. 2017;50(2):237\u201341.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"815_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jac\/dkg380","volume":"52","author":"MW Garrison","year":"2003","unstructured":"Garrison MW. Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae. J Antimicrob Chemother. 2003;52(3):503\u20136.","journal-title":"J Antimicrob Chemother"},{"issue":"23","key":"815_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.21037\/atm.2019.11.33","volume":"7","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Li C, Zhang J, Fu Y, Hu K, Su S, Wang Y, Li H, Zhang X. The in vitro activity of polymyxin B and Tigecycline alone and combination with other antibiotics against carbapenem-resistant Enterobacter cloacae complex isolates, including high-risk clones. Ann Transl Med. 2019;7(23):779.","journal-title":"Ann Transl Med"},{"issue":"12","key":"815_CR39","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1128\/JCM.01121-14","volume":"52","author":"CD Doern","year":"2014","unstructured":"Doern CD. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J Clin Microbiol. 2014;52(12):4124\u20138.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"815_CR40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/jac\/dki477","volume":"57","author":"PJ Petersen","year":"2006","unstructured":"Petersen PJ, Labthavikul P, Jones CH, Bradford PA. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother. 2006;57(3):573\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"815_CR41","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3389\/fmicb.2020.00828","volume":"11","author":"ER Holden","year":"2020","unstructured":"Holden ER, Webber MA. MarA, Rama, and SoxS as mediators of the stress response: survival at a cost. Front Microbiol. 2020;11:828.","journal-title":"Front Microbiol"},{"issue":"5","key":"815_CR42","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1128\/AAC.45.5.1515-1521.2001","volume":"45","author":"H Wang","year":"2001","unstructured":"Wang H, Dzink-Fox JL, Chen M, Levy SB. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from china: role of AcrR mutations. Antimicrob Agents Chemother. 2001;45(5):1515\u201321.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"815_CR43","doi-asserted-by":"publisher","first-page":"6982","DOI":"10.1128\/AAC.03808-14","volume":"58","author":"ZK Sheng","year":"2014","unstructured":"Sheng ZK, Hu F, Wang W, Guo Q, Chen Z, Xu X, Zhu D, Wang M. Mechanisms of Tigecycline resistance among Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother. 2014;58(11):6982\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"815_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijantimicag.2011.02.012","volume":"38","author":"R Rosenblum","year":"2011","unstructured":"Rosenblum R, Khan E, Gonzalez G, Hasan R, Schneiders T. Genetic regulation of the RamA locus and its expression in clinical isolates of Klebsiella pneumoniae. Int J Antimicrob Agents. 2011;38(1):39\u201345.","journal-title":"Int J Antimicrob Agents"},{"key":"815_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01954","volume":"11","author":"NO Eltai","year":"2020","unstructured":"Eltai NO, Kelly B, Al-Mana HA, Ibrahim EB, Yassine HM, Al Thani A, Al Maslmani M, Lammens C, Xavier BB, Malhotra-Kumar S. Identification of mcr-8 in clinical isolates from Qatar and evaluation of their antimicrobial profiles. Front Microbiol. 2020;11: 1954.","journal-title":"Front Microbiol"},{"key":"815_CR46","doi-asserted-by":"crossref","unstructured":"Pitt ME, Elliott AG, Cao MD, Ganesamoorthy D, Karaiskos I, Giamarellou H, Abboud CS, Blaskovich MAT, Cooper MA, Coin LJM. Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae. Microb Genom 2018, 4(3).","DOI":"10.1099\/mgen.0.000158"},{"issue":"1","key":"815_CR47","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/22221751.2021.1906163","volume":"10","author":"Y Yang","year":"2021","unstructured":"Yang Y, Yang Y, Chen G, Lin M, Chen Y, He R, Galvao KN, El-Gawad El-Sayed Ahmed MA, Roberts AP, Wu Y, et al. Molecular characterization of carbapenem-resistant and virulent plasmids in Klebsiella pneumoniae from patients with bloodstream infections in China. Emerg Microbes Infect. 2021;10(1):700\u20139.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"815_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1128\/CMR.00058-14","volume":"28","author":"OM El-Halfawy","year":"2015","unstructured":"El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev. 2015;28(1):191\u2013207.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"815_CR49","doi-asserted-by":"publisher","first-page":"e0015221","DOI":"10.1128\/Spectrum.00152-21","volume":"9","author":"Y Tian","year":"2021","unstructured":"Tian Y, Zhang Q, Wen L, Chen J. Combined effect of polymyxin B and tigecycline to overcome heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae. Microbiol Spectr. 2021;9(2):e0015221.","journal-title":"Microbiol Spectr"},{"key":"815_CR50","doi-asserted-by":"crossref","unstructured":"Gil-Gil T, Berryhill BA, Manuel JA, Smith AP, McCall IC, Baquero F, Levin BR. The evolution of heteroresistance via small colony variants in Escherichia coli following long term exposure to bacteriostatic antibiotics. bioRxiv. 2024.","DOI":"10.1101\/2023.10.30.564761"},{"issue":"11","key":"815_CR51","doi-asserted-by":"publisher","first-page":"13188","DOI":"10.3390\/molecules181113188","volume":"18","author":"S Bernatova","year":"2013","unstructured":"Bernatova S, Samek O, Pilat Z, Sery M, Jezek J, Jakl P, Siler M, Krzyzanek V, Zemanek P, Hola V, et al. Following the mechanisms of bacteriostatic versus bactericidal action using raman spectroscopy. Molecules. 2013;18(11):13188\u201399.","journal-title":"Molecules"},{"key":"815_CR52","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3389\/fmicb.2019.02029","volume":"10","author":"X Ma","year":"2019","unstructured":"Ma X, He Y, Yu X, Cai Y, Zeng J, Cai R, Lu Y, Chen L, Chen C, Huang B. Ceftazidime\/avibactam improves the antibacterial efficacy of polymyxin B against polymyxin B heteroresistant KPC-2-producing Klebsiella pneumoniae and hinders emergence of resistant subpopulation in vitro. Front Microbiol. 2019;10:2029.","journal-title":"Front Microbiol"},{"key":"815_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02448-17","author":"VI Band","year":"2018","unstructured":"Band VI, Satola SW, Burd EM, Farley MM, Jacob JT, Weiss DS. Carbapenem-resistant Klebsiella pneumoniae exhibiting clinically undetected colistin heteroresistance leads to treatment failure in a murine model of infection. mBio. 2018. https:\/\/doi.org\/10.1128\/mBio.02448-17.","journal-title":"mBio"},{"key":"815_CR54","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01815-17","author":"JK Diep","year":"2018","unstructured":"Diep JK, Sharma R, Ellis-Grosse EJ, Abboud CS, Rao GG. Evaluation of activity and emergence of resistance of polymyxin B and ZTI-01 (fosfomycin for injection) against KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2018. https:\/\/doi.org\/10.1128\/AAC.01815-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"815_CR55","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ijantimicag.2016.10.025","volume":"49","author":"R Sharma","year":"2017","unstructured":"Sharma R, Patel S, Abboud C, Diep J, Ly NS, Pogue JM, Kaye KS, Li J, Rao GG. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes. Int J Antimicrob Agents. 2017;49(2):224\u201332.","journal-title":"Int J Antimicrob Agents"},{"key":"815_CR56","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3389\/fmicb.2016.01304","volume":"7","author":"W Ni","year":"2016","unstructured":"Ni W, Wei C, Zhou C, Zhao J, Liang B, Cui J, Wang R, Liu Y. Tigecycline-amikacin combination effectively suppresses the selection of resistance in clinical isolates of KPC-producing Klebsiella pneumoniae. Front Microbiol. 2016;7:1304.","journal-title":"Front Microbiol"},{"issue":"12","key":"815_CR57","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1007\/s12010-021-03664-z","volume":"193","author":"H Wu","year":"2021","unstructured":"Wu H, Feng H, He L, Zhang H, Xu P. In vitro activities of Tigecycline in combination with Amikacin or colistin against Carbapenem-Resistant Acinetobacter baumannii. Appl Biochem Biotechnol. 2021;193(12):3867\u201376.","journal-title":"Appl Biochem Biotechnol"},{"issue":"5","key":"815_CR58","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10096-022-04429-0","volume":"41","author":"YM Demirlenk","year":"2022","unstructured":"Demirlenk YM, G\u00fccer LS, U\u00e7ku D, Tanr\u0131\u00f6ver C, Akyol M, Kalay Z, Bar\u00e7\u0131n E, Akcan RE, Can F, G\u00f6nen M, et al. A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Eur J Clin Microbiol Infect Dis. 2022;41(5):761\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-025-00815-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:29:26Z","timestamp":1759274966000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-025-00815-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1186\/s12941-025-00815-6","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in vitro and did not involve human subjects. Written informed consent was not required, as per the guidelines of the institutional ethics, biosecurity, and research committees, since the bacterial strains used were sourced from clinical laboratories in hospitals. All the authors read and approved the final manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}